SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-16-001004
Filing Date
2016-04-28
Accepted
2016-04-28 13:44:36
Documents
8
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F repcf_20f-20151231.htm 20-F 1424928
2 EX-12.1 ex-12_1.htm EX-12.1 11019
3 EX-12.2 ex-12_2.htm EX-12.2 10917
4 EX-13.1 ex-13_1.htm EX-13.1 7337
5 EX-13.2 ex-13_2.htm EX-13.2 7341
6 EX-15.1 ex-15_1.htm EX-15.1 3701
7 image0.jpg GRAPHIC 17677
8 image00001.jpg GRAPHIC 5730
  Complete submission text file 0001640334-16-001004.txt   1499015
Mailing Address SUITE 2020 - 401 WEST GEORGIA STREET VANCOUVER BC A1 V6B 5A1
Business Address SUITE 2020 - 401 WEST GEORGIA STREET VANCOUVER BC A1 V6B 5A1 604-248-8730
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-50112 | Film No.: 161598893
SIC: 1040 Gold and Silver Ores
Assistant Director 9